Ameriprise’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $5.14M | Sell |
|
|||||
|
2024
Q4 | $43.6M | Sell |
|
|||||
|
2024
Q3 | $38.8M | Buy |
|
|||||
|
2024
Q2 | $23.5M | Sell |
|
|||||
|
2024
Q1 | $28.5M | Buy |
|
|||||
|
2023
Q4 | $7.46M | Buy |
|
|||||
|
2023
Q3 | $3.78M | Sell |
|
|||||
|
2023
Q2 | $4.92M | Sell |
|
|||||
|
2023
Q1 | $4.37M | Buy |
|
|||||
|
2022
Q4 | $2.62M | Buy |
|
|||||
|
2022
Q3 | $343K | Sell |
|
|||||
|
2022
Q2 | $498K | Buy |
|
|||||
|
2022
Q1 | $458K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $288K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $149K | Buy |
|
|||||
|
2016
Q3 | – | Sell |
|
|||||
|
2016
Q2 | $328K | Buy |
|
|||||
|
2016
Q1 | $231K | Sell |
|
|||||
|
2015
Q4 | $3.27M | Buy |
|
|||||
|
2015
Q3 | $1.7M | Sell |
|
|||||
|
2015
Q2 | $1.52M | Buy |
|
|||||
|
2014
Q4 | – | Sell |
|
|||||
|
2014
Q3 | $0 | Buy |
|